P

Inventor

DALLAVALLE SABRINA

IT12 patents
⚠️ This page may combine multiple inventors who share the name “DALLAVALLE SABRINA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SIGMA TAU IND FARMACEUTI

5 patents
US7449495B2Nov 11, 2008

Retinoid derivatives with antiangiogenic, antitumoral and proapoptotic activities

SIGMA TAU IND FARMACEUTI7 citations73
US7705012B2Apr 27, 2010

Camptothecins conjugated in position 7 to cyclic peptides as cytostatic agents

SIGMA TAU IND FARMACEUTI4 citations59
US7728039B2Jun 1, 2010

Biphenyl and Naphthyl-Phenyl Hydroxamic Acid Derivatives

SIGMA TAU IND FARMACEUTI0 citations51
US7351714B2Apr 1, 2008

7-imino derivatives of camptothecin having antitumor activity

SIGMA TAU IND FARMACEUTI0 citations51
US7589099B2Sep 15, 2009

7-t-butoxyiminomethylcamptothecin conjugated in position 20 with integrin antagonists

SIGMA TAU IND FARMACEUTI1 citations49

BIOGEM S C A R L

3 patents
US11364216B2Jun 21, 2022

Retinoid derivatives with antitumor activity

BIOGEM S C A R L2 citations68
US10905668B2Feb 2, 2021

Retinoid derivatives with antitumor activity

BIOGEM S C A R L5 citations68
US11819484B2Nov 21, 2023

Retinoid derivatives with antitumor activity

BIOGEM S C A R L0 citations58

ISTITUO NAZ PER LO STUDIO E LA

1 patent
US7105492B2Sep 12, 2006

Camptothecin derivatives having antitumor activity

ISTITUO NAZ PER LO STUDIO E LA9 citations68

MERLINI LUCIO

1 patent
US8101793B2Jan 24, 2012

Retinoid derivatives with antiangiogenic, antitumoral and proapoptotic activities

MERLINI LUCIO3 citations56

CABRI WALTER

1 patent
US8530517B2Sep 10, 2013

Retinoid derivatives endowed with cytotoxic and/or antiangiogenic properties

CABRI WALTER0 citations36

FONDAZIONE IRCCS ISTITUTO NAZ DEI TUMORI

1 patent
US10093621B2Oct 9, 2018

4-oxo-N-(4-hydroxyphenyl)retinamide derivatives as therapeutic agents for the treatment of cancer

FONDAZIONE IRCCS ISTITUTO NAZ DEI TUMORI0 citations33